Adage Capital Partners Gp, L.L.C. Insmed Inc Transaction History

Adage Capital Partners Gp, L.L.C.

$56.4 Billion
Q2 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Insmed Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,859,452 shares of INSM stock, worth $453 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

2,859,452

Previous 3,446,944 17.04%

Holding current value

$453 Million

Previous $263 Million 9.43%

% of portfolio

0.51%

Previous 0.51%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$64.81 - $105.9 $38.1 Million - $62.2 Million	-587,492 Reduced 17.04%	2,859,452 $288 Million
Q1 2025 May 15, 2025	BUY	$65.25 - $83.83 $117 Million - $151 Million	1,799,382 Added 109.21%	3,446,944 $263 Million
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $40.8 Million - $47.1 Million	615,000 Added 59.56%	1,647,562 $114 Million
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $18.1 Million - $23.1 Million	-292,438 Reduced 22.07%	1,032,562 $75.4 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $23.7 Million - $74.9 Million	1,075,000 Added 430.0%	1,325,000 $88.8 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $9 Million - $10.5 Million	-350,000 Reduced 58.33%	250,000 $6.78 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $11.9 Million - $16.2 Million	600,000 New	600,000 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $2.16 Million - $2.92 Million	103,500 Added 27.86%	475,000 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $6.34 Million - $9.55 Million	371,500 New	371,500 $7.33 Million
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $3.08 Million - $5.13 Million	-199,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $5.68 Million - $7.95 Million	-247,000 Reduced 55.38%	199,000 $5.09 Million
Q1 2019 May 15, 2019	SELL	$13.91 - $31.15 $3.14 Million - $7.04 Million	-226,000 Reduced 33.63%	446,000 $13 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $6.7 Million - $10.8 Million	-578,000 Reduced 46.24%	672,000 $8.82 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $7.2 Million - $10.7 Million	360,000 Added 40.45%	1,250,000 $29.6 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $3.69 Million - $5.61 Million	169,966 Added 23.61%	890,000 $20 Million
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $19 Million - $22.9 Million	720,034	720,034 $22.5 Million

Others Institutions Holding INSM

# of Institutions

581

Shares Held

203M

Call Options Held

2.84M

Put Options Held

3.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $21.4B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Insmed Inc Transaction History